Press Releases

University of Szeged installed Hungary’s first Robotic Magnetic Navigation system in JulyOver 70 patients with all forms of arrhythmia treated robotically to date, a record pace of use globallyRobotics enabled successful treatment of patients with multiple previously failed ablation proceduresUniversity of Szeged to celebrate leadership in technology and grand opening of Robotic Cardiology Program at upcoming scientific symposium on September 8th ST. LOUIS, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that the Electrophysiology team at the University of Szeged

CARMEL, Ind., Sept. 3, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that, in partnership with HealthSync, it has been accepted into the CMS (Centers for Medicare & Medicaid) ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model. Inclusion in the federal program reinforces the Company's commitment to helping providers improve behavioral health outcomes while making solutions more affordable for patients. As part of

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (NASDAQ:AGMH, "AGMH" or the "Company")), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, today provided an update on the latest commercialization progress in its AI infrastructure business and stated that it expects a significant increase in hardware delivery volumes and the scale of its related technical services in the second half of 2026. Driven by surging demand for high-performance data storage from companies engaged in the research and development of large AI models and cloud computing service providers, AGMH’s full-stack solutions, cen

HONG KONG, Sept. 03, 2026 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (NASDAQ:MASK) (the "Company" or "3 E Network"), a business-to-business ("B2B") information technology ("IT") business solutions provider, committed to becoming a next-generation artificial intelligence ("AI") infrastructure solutions provider, today announced that it has entered into a securities purchase agreement with an entity controlled by its Chief Executive Officer, Dr. Tingjun Yang. Under the agreement, the Company will conduct a $1 million private placement with the entity. The proceeds from this private placement will be used for general working capital purposes to support the Company’s ongoing res

Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, today published its monthly origination volume for August 2026 and its latest Upstart Macro Index (UMI) reading. For historical data and more information, see upstart.com/volume and upstart.com/umi. Monthly Origination Volume Period Originations Origination days Originations, Dollars per day August 2026 $1,342.1M 26.5 $50.7M September 3, 2026 UMI The current UMI is 1.50, in line with the August 3, 2026 UMI. For reference, a UMI of 1.50 is approximately 50% above what Upstart would expect in a normal economy (a UMI of 1.0). UMI has rem

Repurchase reduces unsecured note balance to approximately $364.7 millionManagement to discuss this key milestone and broader transformation progress at upcoming investor conferences GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the repurchase of $75 million aggregate principal amount of its 3.875% Senior Unsecured Notes due 2028 (the "Senior Unsecured Notes"), following authorization granted by its Board of Directors. In total, Emergent deployed approximately $68 million of cash for the repurchases, resulting in an average repurchase price of 90.6% of face value. Following completion of the repurchases

HPE (NYSE:HPE) will host its Networking Investor Day on September 30, 2026, in Sunnyvale, California. Join the live webcast for an in-depth presentation on the HPE Networking business from Rami Rahim, executive vice president, president, and general manager, Networking, HPE. Additional Networking executives will also participate in the event and take part in a live panel discussion. The program will highlight HPE Networking’s strategy, portfolio differentiation, and growth opportunities, and include a live Q&A session. The webcast will begin Wednesday, September 30, at 10:30 a.m. CT (8:30 a.m. PT) and will be available at www.hpe.com/investor/NetworkingInvestorDay2026. A replay of the

Accomplished global HR executive brings an established record of leading enterprise transformation and building high-performance cultures across packaging and manufacturing organizations.ATLANTA, Sept. 3, 2026 /PRNewswire/ -- Graphic Packaging Holding Company (NYSE:GPK), a global leader in sustainable consumer packaging, today announced that Tatiana Berardinelli has been appointed Executive Vice President and Chief Human Resources Officer, effective Sept. 8. She will report to President and Chief Executive Officer Robbert Rietbroek and serve on the Company's Executive Leadership Team. Berardinelli's impact across 25 years of gl

Milestone reflects data-driven innovation at Truist and their growing personalization engine, delivering proactive insights and advice that help clients better understand, manage and act on their financial lives.Why it matters: Truist Insights has generated more than 2 billion personalized financial insights and advice for consumer, small business and wealth clients since 2023, helping clients spot patterns, understand changes and take action with more confidence.What's new: Truist is embedding proactive insights where clients already engage digitally, within account details, planning dashboards, and Truist Assist, including delivering timely push notifications for urgent insights.The impact

TORONTO, Sept. 3, 2026 /CNW/ -- DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (NASDAQ:DEFT) (CBOE CA: DEFI) (GR: R9B) (B3: DEFT31), a financial technology company bridging the gap between traditional capital markets and decentralized finance ("DeFi"), today announced that it has received written notification from The Nasdaq Stock Market LLC ("Nasdaq") granting the Company an additional 180-calendar-day period, or until March 1, 2027, to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule"). The Company qualified for the additional compli

Strength in Research and AI offset by prior year comparison and softness in Learning – Emerald integration ahead of schedule Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the first quarter ended July 31, 2026. First Quarter Summary GAAP performance vs. prior year: Revenue of $386 million vs. $397 million (-3%); Operating Income of $3 million vs. $31 million and Diluted Earnings Per Share (EPS) of $(0.23) vs. $0.22 largely due to restructuring charges and acquisition and integration related costs. Adjusted Results at constant currency: Revenue of

A Multi-Year Collaboration Delivering Academic Programming, Student Opportunity, and Career Pathways Across all NSU's campuses and Northeast OklahomaVenu Holding Corporation ("VENU" or the "Company") (NYSE:VENU), an owner, operator, and developer of premium live entertainment destinations, and Northeastern State University (NSU), Oklahoma's oldest institution of higher education, today announced a long-term partnership with VENU's Regent Bank Amphitheater in Broken Arrow, Oklahoma.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260903000843/en/VENU's Regent Bank Amphitheater Partners with Northeastern State University to Further Ar

Collaboration covers settlement cycle modernization, extended trading hours, ETFs, and market data and index products The New York Stock Exchange, part of Intercontinental Exchange, Inc. (NYSE:ICE), one of the world's leading providers of financial market technology and data powering global capital markets, and Korea Exchange, the sole securities exchange operator in the Republic of Korea, today announced the signing of a memorandum of understanding to collaborate on a number of key business activities aimed at expanding access to global capital markets. The collaboration leverages the expertise of both exchanges to drive innovation across U.S. and Korean markets. The exchanges may esta

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it is scheduled to participate in the following upcoming investor events: 2026 Cantor Global Healthcare Conference – September 9-11, 2026 Type: Fireside Chat Presentation Date/Time: September 10, 2026, 10:55 am EDT Morgan Stanley 24th Annual Global Healthcare Conference – September 14-16, 2026 Type: Fireside Chat Presentation Date/Time: September 15, 2026, 11:30 am EDT H.C. Wainwright 28th Annual Global Investment Conference – September 14-16, 2026 Type: Fireside Chat Presentation Date/Time: September 16, 2026, 9:00 am EDT Presentation materials and webcast links, if applicable, may be accessed on the Events an

SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in three upcoming healthcare conferences in September: 2026 Cantor Global Healthcare ConferenceDate: Thursday, September 10Format: Fireside chat and 1x1 meetingsTime: 3:55 – 4:25 PM EDTLocation: New York, NY Morgan Stanley 24th Annual Global Healthcare ConferenceDate: Wednesday, September 16Format: Fireside chat and 1x1 meetingsTime: 10:45 – 11:20 AM EDTLocation: New York, NY Bernstein’s 3rd Annual H

Fast Track designation underscores the significant unmet need for patients with systemic sclerosis-associated Raynaud's phenomenon (SSc-RP), a debilitating manifestation affecting up to 90% of SSc patientsNo therapy is currently approved in the U.S. to treat SSc-RP and management options are limited and often inadequate for patients with more severe diseaseLiquidia plans to initiate RE-WARM, a Phase 2a dose-finding study of YUTREPIA in SSc-RP, in the fourth quarter of 2026 MORRISVILLE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and

TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ:ELBM, TSXV:ELBM) ("Electra" or the "Company"), a leader in advancing North America’s critical minerals processing, today announced is upcoming schedule of investor and industry engagement for September as the Company continues to advance construction of its Ontario cobalt sulfate refinery and its broader North American critical minerals strategy. Members of Electra’s executive leadership team will participate in leading industry and investment conferences across North America, complemented by select investor and strategic meetings. These engagements provide Electra with an opportunity to connect dir

MILLBRAE, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (NASDAQ:EIKN) ("Eikon"), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced the appointment of Ching-Pin ("CP") Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer. Dr. Chang is a physician-scientist and accomplished research leader with more than two decades of experience spanning academic medicine, foundational research, and drug discovery. He joins Eikon from Bristol Myers Squibb, where he most recently served as Vice President, Head of Cardiovascular Discovery Biology and Translational Ph

NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (NASDAQ:TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced that senior management will participate in the following conferences in September. 2026 Cantor Global Healthcare ConferenceSeptember 9-11, 2026, New York, New YorkFireside Chat: September 10, 10:55 a.m. to 11:25 a.m. ETTrevi Representatives: Jennifer Good, President and CEO, and David Hastings, CFOTo

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Cantor Global Healthcare Conference, being held on September 9 - 11, 2026. The fireside chat is scheduled to take place on Wednesday, September 9, 2026, at 11:30am ET. A live webcast of the fireside chat will be available on the Events page, located within the Investors & Media section, of the Company’s website at http://ir.tgtherapeutics.com/events. ABOUT TG THERAPEUTICSTG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and com